| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Workplace Communication > Connecting to People in Business Relationships - the Universal Principles Checklist |
|
Just Other Articles - Connecting to People in Business Relationships - the Universal Principles Checklist
The following check list is an excellent tool with which to evaluate and monitor your business relationships. This list is based on the Emergence Personalty Theory's Six Universal Principles of Connect According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ing in Business. Please note, in order to benefit from this check list, you must be mentally present and able to picture each line. No internal pictures. No real benefits. Moreover, this hold true even ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in is you can quote back the entire text line by line. In other words, just as parroted sales pitches are the fastest way to kill a sale, attempts to parrot learning is the fastest way to miss the benef lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. t in any kind of learning. The point? Give yourself time for each line to sink in. And try to find a personal story for each and every check point. Only then can you claim to have heard what has been here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe said. Only then will your business relationships become what you and your clients deserve; the best you can be. the First Principle: ARRIVING
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rived? ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rmous. Mutual Dialogue exists only while you both arrive. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi Library of Information to find relevant financial wisdom.the Second Principle: ONLY EXPERIENCE TEACHES
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically I can not remember much of the type on all the pages of the book I just set down. Yet, I can recall a life experience vividly from many years ago. This experience reveals the essence of this principl and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ : If you can not picture it, you have not learned it. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ich Mutual Dialogue continues to occur.the Third Principle: CONTAINERS
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Do I learn the size of the each person's container at my meetings? dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ould I ever waste my time or theirs?
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin tisfy two factors in each and every situation. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen unwanted and unnecessary complication.the Fifth Principle: THERE WILL ALWAYS BE TOO MUCH INFORMATION
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel at hand? If I think I have the answer, would another opinion shed an alternate proposal? ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust cover ? y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ing information on the Internet to taking a drink of cold water from a fire hose? < . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de l> elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip making any major changes to the original item? Finally, remember, in order for something to be a Universal Principle, it must always be true and always be the opposite of a Universal Problem tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Finding The Right Business Grants
|